BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7178141)

  • 1. Therapeutic plasmapheresis in patients with antibodies to high-frequency red cell antigens.
    Steane EA; Sheehan RG; Brooks BD; Frenkel EP
    Prog Clin Biol Res; 1982; 106():347-53. PubMed ID: 7178141
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved antiglobulin tests to detect difficult antibodies: detection of anti-Kell by LISS.
    Voak D; Downie M; Haigh T; Cook N
    Med Lab Sci; 1982 Oct; 39(4):363-70. PubMed ID: 7176849
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serologic incompatibility and family planning].
    Matýsek P; Ungerová A; Cuprová M; Muchová M
    Cesk Gynekol; 1988 Aug; 53(7):497-9. PubMed ID: 3168017
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K22, a 'new' para-Kell antigen of high frequency.
    Bar Shany S; Ben Porath D; Levene C; Sela R; Daniels GL
    Vox Sang; 1982 Feb; 42(2):87-90. PubMed ID: 7064432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody anti-Kell (K1). An analysis of two post-transfusion haemolytic reactions (author's transl)].
    Fischer O; Snopková O
    Cas Lek Cesk; 1981 Jan; 120(3-4):96-9. PubMed ID: 7214435
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood transfusion complications due to Kell factor incompatibility of the transfused blood].
    Skachilova NN; Umnova MA; Morozova AD; Shakhsuvarov VD; Beliaev VV
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):16-20. PubMed ID: 7156084
    [No Abstract]   [Full Text] [Related]  

  • 8. Red cell antigens. The fetus as a patient.
    Huntley B
    Lancet; 2001 Dec; 358 Suppl():S58. PubMed ID: 11784607
    [No Abstract]   [Full Text] [Related]  

  • 9. Interdonor incompatibility due to anti-Kell antibody undetectable by automated antibody screening.
    West NC; Jenkins JA; Johnston BR; Modi N
    Vox Sang; 1986; 50(3):174-6. PubMed ID: 3716289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstacle to red cell engraftment due to major ABO incompatibility in allogeneic bone marrow transplants (BMT): quantitative and kinetic aspects in 58 BMTs.
    Reviron J; Schenmetzler C; Bussel A; Frappaz D; Devergie A; Gluckman E
    Transplant Proc; 1987 Dec; 19(6):4618-22. PubMed ID: 3321633
    [No Abstract]   [Full Text] [Related]  

  • 11. Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid.
    Berkowitz RL; Beyth Y; Sadovsky E
    Obstet Gynecol; 1982 Dec; 60(6):746-9. PubMed ID: 7145281
    [No Abstract]   [Full Text] [Related]  

  • 12. The Day phenotype: a "new" variant in the Kell blood group system.
    Brown A; Berger R; Lasko D; Brokenshire D; Humphreys J; Stout T; Moore BP; Johnson CL; Mueller KA; Marsh WL
    Rev Fr Transfus Immunohematol; 1982 Dec; 25(6):619-27. PubMed ID: 7170568
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood transfusion complication in a female patient with a rare KK blood genotype].
    Umnova MA; Skachilova NN; Piskunova TM; Ichalovskaia TA; Morozova AD
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):45-9. PubMed ID: 7156087
    [No Abstract]   [Full Text] [Related]  

  • 14. The Gerbich blood group antigens: a review.
    Reid ME
    Med Lab Sci; 1986 Apr; 43(2):177-82. PubMed ID: 3526073
    [No Abstract]   [Full Text] [Related]  

  • 15. Two additional examples of non-transfusion-stimulated anti-Kell.
    Clark A; Monaghan WP; Martin CA
    Am J Med Technol; 1981 Dec; 47(12):983-4. PubMed ID: 7332023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed hemolytic transfusion reaction caused by anti-Jsb in a Js(a+b+) patient.
    Waheed A; Kennedy MS
    Transfusion; 1982; 22(2):161-2. PubMed ID: 6978557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of a new case of absence of erythrocyte antigens of the Kell system (Peltz phenotype)].
    Gómez Casal F; Poderós C; Soler H; Romero MS; Fuertes MA; Callén L; Tres A; Gutiérrez M
    Med Clin (Barc); 1983 Jan; 80(1):50-1. PubMed ID: 6834918
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of anti-Coa antibodies of the Colton blood group system and their significance in hemotherapy].
    Kuśnierz G; Bragiel I; Nowakowska E; Cwirko Z
    Acta Haematol Pol; 1983; 14(2):117-24. PubMed ID: 6673468
    [No Abstract]   [Full Text] [Related]  

  • 19. [Obstetrical supervision of fetomaternal blood group incompatibilities].
    Chavinie J; Poissonnier MH
    Soins Gynecol Obstet Pueric Pediatr; 1983; (27-28):21-3. PubMed ID: 6558875
    [No Abstract]   [Full Text] [Related]  

  • 20. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.